Portfolio Holdings Detail for ISIN IE0007O06KL9
Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /var/www/liquidata/show_ticker_holding_ETFs.php on line 67
Stock Name / FundiShares Russell 2000 Swap UCITS ETF
IssuerBlackrock
ETF TickerRU2K.AS(USD) CXE
ETF TickerRU2K(USD) Euronext Amsterdam

Holdings detail for LLY

Stock NameEli Lilly and Company
TickerLLY(EUR) F
TYPECommon Stock
CountryGermany
ISINUS5324571083
LEIFRDRIPF3EKNDJ2CQJL29

Show aggregate LLY holdings

News associated with LLY

Notable Friday Option Activity: AMD, LLY, BKNG
Looking at options trading activity among components of the S&P 500 index, there is noteworthy activity today in Advanced Micro Devices Inc (Symbol: AMD), where a total volume of 570,924 contracts has been traded thus far today, a contract volume which is representative of a - 2025-09-19 14:45:00
Boost Your Portfolio With These Top-Ranked ETFs
With the Fed's first 2025 rate cut and upgraded growth outlook, ETFs in tech, financials, industrials and health care could benefit from momentum. - 2025-09-19 13:03:00
3 Dividend Growth Stocks You Can Buy and Forget About
Key PointsThese stocks offer seemingly low yields of less than 1%. - 2025-09-18 05:50:00
JPMorgan Chase & Co. Has Lowered Expectations for Eli Lilly and Company (NYSE:LLY) Stock Price
Eli Lilly and Company (NYSE:LLY – Get Free Report) had its price objective decreased by JPMorgan Chase & Co. from $1,100.00 to $1,050.00 in a research report issued on Tuesday,Benzinga reports. The brokerage presently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s price target indicates a potential upside of 38.09% from the […] - 2025-09-18 02:56:56
Lilly's Orforglipron Achieves Significant Weight Loss In Phase 3 Trial
(RTTNews) - Eli Lilly and Co. (LLY) announced detailed results from its Phase 3 ATTAIN-1 trial, evaluating the safety and efficacy of orforglipron—an investigational oral glucagon-like peptide-1 (GLP-1) receptor agonist—in adults with obesity, or those overweight with a weight-re - 2025-09-17 00:35:16
XLV, LLY, TMO, PFE: Large Inflows Detected at ETF
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the The Health Care Select Sector SPDR Fund (Symbol: XLV) where we have detected an approximate $308.0 million dollar inflow -- that's a 0.9% increase we - 2025-09-16 11:47:58
S&P 500 Analyst Moves: LLY
The latest tally of analyst opinions from the major brokerage houses shows that among the components of the S&P 500 index, Eli Lilly is now the #61 analyst pick, moving up by 1 spot. This rank is formed by averaging the analyst opinions for each component from each - 2025-09-15 14:35:56
Why Novo Nordisk Stock Popped Today
Key PointsLondon's Financial Times highlights improved weight loss from taking more Ozempic. - 2025-09-15 12:34:46
Sen. John Boozman Buys Eli Lilly and Company (NYSE:LLY) Stock
Senator John Boozman (R-Arkansas) recently bought shares of Eli Lilly and Company (NYSE:LLY). In a filing disclosed on September 12th, the Senator disclosed that they had bought between $1,001 and $15,000 in Eli Lilly and Company stock on August 11th. Senator John Boozman also recently made the following trade(s): Purchased $1,001 – $15,000 in shares […] - 2025-09-15 03:12:42
3 Monster Stocks to Hold for the Next 5 Years
Key PointsAmazon should improve its profits and margins, based on its cloud computing and AI initiatives. - 2025-09-14 08:45:00
2 Beaten-Down Stocks to Buy and Hold Forever
Key PointsApple and Eli Lilly have impressive long-term track records of returns. - 2025-09-13 08:45:00
2 Monster Stocks to Hold for the Next 5 Years
Key PointsThese stocks have climbed in the triple digits over the past three years. - 2025-09-11 05:20:00
IWB, LLY, ORCL, CVX: Large Inflows Detected at ETF
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Russell 1000 ETF (Symbol: IWB) where we have detected an approximate $462.9 million dollar inflow -- that's a 1.1% increase week over week in - 2025-09-08 12:03:03
Down 34%, Should You Buy the Dip on Viking Therapeutics?
Key PointsViking Therapeutics is working on an injectable weight loss drug candidate and one in pill format. - 2025-09-05 05:10:00
The 6 Best Stocks to Buy Right Now in September (2025)!
My list of best stocks to buy has outperformed the broader market indexes by a significant margin. - 2025-09-04 06:00:00
The Problem With Weight Loss Stocks
In this Motley Fool Money episode, Motley Fool analysts Rick Munarriz and Karl Thiel and contributor Jason Hall dig into the problems with weight loss stocks. They also look at some investments that can survive near-term potential volatility as well as give a long-term view of di - 2025-09-03 14:48:00
NVO's Wegovy vs. LLY's Tirzepatide: Who Leads in Heart Risk Reduction?
Novo Nordisk's Wegovy shows a stronger reduction in heart risks compared to Eli Lilly's tirzepatide in real-world data from the STEER study. - 2025-09-01 11:54:00
The Zacks Analyst Blog Highlights Lilly, Oracle, Procter & Gamble and Comstock Holding Companies
Zacks spotlights Eli Lilly, Oracle, Procter & Gamble, and microcap Comstock Holding, with pharma and staples facing pressure while Oracle and Comstock show momentum. - 2025-08-29 13:58:00
Nvidia's $46.7 Billion Quarter Shows the AI Trade Is Alive and Well -- With Caveats
Key PointsWhile earnings were up 56%, the company's data center revenue dropped 1% sequentially. - 2025-08-29 05:45:00
Top Stock Reports for Eli Lilly, Oracle & Procter & Gamble
Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly, Oracle, and Procter & Gamble, as well as a micro-cap stock, Comstock. - 2025-08-28 18:59:00
2 Growth Stocks That Could Be Worth $1 Trillion in 5 Years
Key PointsEli Lilly's work in weight management should help it surpass some industry sales records. - 2025-08-28 10:45:00
2 High-Yield Dividend Stocks You Can Buy With $200 Now and Hold at Least a Decade
Key PointsDividend-paying stocks tend to outperform non-dividend-paying stocks by a mile. - 2025-08-28 04:26:00
As the Market Rotates, This Healthcare ETF Is Leading the Way
Over the past month, the market has undergone a rotation that’s seen tech sell-off and defensive sectors like healthcare reap the rewards. The jury remains out on whether this shift indicates a more inclusive rally or if it should raise questions about the bull market’s footing. - 2025-08-26 10:35:00
When AI Execs Say the Market Looks Bubbly
In this podcast, Motley Fool contributors Tyler Crowe, Lou Whiteman, and Rachel Warren discuss: - 2025-08-25 14:47:00
Eli Lilly and Company (NYSE:LLY) and Innoviva (NASDAQ:INVA) Financial Analysis
Eli Lilly and Company (NYSE:LLY – Get Free Report) and Innoviva (NASDAQ:INVA – Get Free Report) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, risk, dividends and earnings. Institutional & Insider Ownership 82.5% of Eli […] - 2025-08-25 04:38:49
The S&P 500 Hasn't Yielded This Little Since the Dot-Com Bubble. Here's What Investors Can Do.
Key PointsThe S&P 500's rising yield is similar to what happened before the dot-com bubble burst. - 2025-08-24 15:23:00
The Best Stocks to Invest $50,000 in Right Now
Key PointsIf you have a lump sum of money, look for long-term performance and stability. - 2025-08-24 05:32:00
If I Could Only Buy 1 S&P 500 Stock From Each Sector for the Rest of 2025, I'd Go With These 11 Dividend Stocks
Key PointsSome stock market sectors significantly impact the S&P 500, whereas others barely make a dent. - 2025-08-23 19:05:00
Is the Vanguard Mega Cap ETF the Simplest Way to Invest in the Top S&P 500 Stocks?
Key PointsThe fund targets the 37% largest S&P 500 components by market cap. - 2025-08-23 17:05:00
Warren Buffett Makes a Big Buy
In this podcast, Motley Fool contributors Travis Hoium, Lou Whiteman, and Rick Munarriz discuss: - 2025-08-22 17:55:00

iShares Russell 2000 Swap UCITS ETF LLY holdings

DateNumber of LLY Shares HeldBase Market Value of LLY SharesLocal Market Value of LLY SharesChange in LLY Shares HeldChange in LLY Base ValueCurrent Price per LLY Share HeldPrevious Price per LLY Share Held
2025-11-27 (Thursday)-2,711LLY holding increased by 5422USD -2,993,866LLY holding increased by 5987732USD -2,993,8665,422USD 5,987,732 USD 1104.34 USD 0
2025-11-27 (Thursday)2,711LLY holding increased by 5422USD 2,993,866LLY holding increased by 5987732USD 2,993,8665,422USD 5,987,732 USD 1104.34 USD 0
2025-11-26 (Wednesday)-2,711LLY holding increased by 5422USD -2,993,866LLY holding increased by 6002913USD -2,993,8665,422USD 6,002,913 USD 1104.34 USD 0
2025-11-26 (Wednesday)2,711LLY holding increased by 5422USD 2,993,866LLY holding increased by 6002913USD 2,993,8665,422USD 6,002,913 USD 1104.34 USD 0
2025-11-25 (Tuesday)-2,711LLY holding increased by 5422USD -3,009,047LLY holding increased by 5910251USD -3,009,0475,422USD 5,910,251 USD 1109.94 USD 0
2025-11-25 (Tuesday)2,711LLY holding increased by 5422USD 3,009,047LLY holding increased by 5910251USD 3,009,0475,422USD 5,910,251 USD 1109.94 USD 0
2025-11-24 (Monday)-2,711LLY holding increased by 5422USD -2,901,204LLY holding increased by 5774051USD -2,901,2045,422USD 5,774,051 USD 1070.16 USD 0
2025-11-24 (Monday)2,711LLY holding increased by 5422USD 2,901,204LLY holding increased by 5774051USD 2,901,2045,422USD 5,774,051 USD 1070.16 USD 0
2025-11-21 (Friday)-2,711LLY holding increased by 5422USD -2,872,847LLY holding increased by 5701206USD -2,872,8475,422USD 5,701,206 USD 1059.7 USD 0
2025-11-21 (Friday)2,711LLY holding increased by 5422USD 2,872,847LLY holding increased by 5701206USD 2,872,8475,422USD 5,701,206 USD 1059.7 USD 0
2025-11-20 (Thursday)-2,711LLY holding increased by 5422USD -2,828,359LLY holding increased by 5673825USD -2,828,3595,422USD 5,673,825 USD 1043.29 USD 0
2025-11-20 (Thursday)2,711LLY holding increased by 5422USD 2,828,359LLY holding increased by 5673825USD 2,828,3595,422USD 5,673,825 USD 1043.29 USD 0
2025-11-19 (Wednesday)-2,711LLY holding increased by 5422USD -2,845,466LLY holding increased by 5637932USD -2,845,4665,422USD 5,637,932 USD 1049.6 USD 0
2025-11-19 (Wednesday)2,711LLY holding increased by 5422USD 2,845,466LLY holding increased by 5637932USD 2,845,4665,422USD 5,637,932 USD 1049.6 USD 0
2025-11-18 (Tuesday)-2,711LLY holding decreased by -5422USD -2,792,466LLY holding decreased by -5584932USD -2,792,466-5,422USD -5,584,932 USD 114.09 USD 0
2025-11-18 (Tuesday)2,711LLY holding decreased by -5422USD 2,792,466LLY holding decreased by -5584932USD 2,792,466-5,422USD -5,584,932 USD 114.09 USD 0
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of LLY by Blackrock for IE0007O06KL9

Show aggregate share trades of LLY

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-11-27BUY5,422 1,104.340* 816.18
2025-11-26BUY5,4221,111.9901,098.100 1,099.489EUR 5,961,429 813.47
2025-11-26BUY5,4221,111.9901,098.100 1,099.489EUR 5,961,429 813.47
2025-11-25BUY5,4221,111.1101,073.250 1,077.036EUR 5,839,689 810.64
2025-11-24BUY5,4221,075.7201,049.380 1,052.014EUR 5,704,020 808.15
2025-11-21BUY5,4221,066.6501,038.000 1,040.865EUR 5,643,570 805.70
2025-11-20BUY5,4221,057.0001,038.250 1,040.125EUR 5,639,558 803.37
2025-11-19BUY5,4221,055.5501,026.250 1,029.180EUR 5,580,214 800.94
2025-11-18SELL-5,4221,040.7241,017.255 1,019.602EUR -5,528,282 807.81 Loss of -1,148,363 on sale
2025-10-30BUY506853.000812.250 816.325EUR 413,060 807.43
2025-10-29BUY506813.530830.290 828.614EUR 419,279 807.37
2025-10-28BUY506820.100829.460 828.524EUR 419,233 807.24
2025-10-27BUY506826.410826.420 826.419EUR 418,168 807.04
2025-10-24BUY506825.450834.150 833.280EUR 421,640 806.85
2025-10-23BUY506821.040824.700 824.334EUR 417,113 806.70
2025-10-22BUY506812.430815.940 815.589EUR 412,688 806.63
2025-10-21BUY506799.570812.990 811.648EUR 410,694 806.71
2025-10-20BUY506808.960809.410 809.365EUR 409,539 806.69
2025-10-17BUY506802.830804.440 804.279EUR 406,965 806.73
2025-10-16BUY506819.380834.700 833.168EUR 421,583 806.59
2025-10-15BUY506826.570830.190 829.828EUR 419,893 806.36
2025-10-14BUY506812.350822.090 821.116EUR 415,485 806.29
2025-10-13SELL-506819.400835.320 833.728EUR -421,866 809.98 Loss of -12,015 on sale
2025-10-09BUY506855.350860.250 859.760EUR 435,039 809.45
2025-10-07BUY506843.630848.540 848.049EUR 429,113 809.04
2025-10-06BUY506845.050856.570 855.418EUR 432,842 808.61
2025-10-03BUY506839.870848.130 847.304EUR 428,736 808.23
2025-10-02BUY506819.850834.460 832.999EUR 421,498 808.08
2025-10-01BUY506825.420833.300 832.512EUR 421,251 807.87
2025-09-30BUY506763.000766.350 766.015EUR 387,604 808.44
2025-09-29BUY506726.510727.860 727.725EUR 368,229 809.49
2025-09-26SELL-506724.540729.000 728.554EUR -368,648 813.56 Profit of 43,012 on sale
2025-05-14BUY72715.560759.500 755.106EUR 54,368 814.85
2025-05-13BUY72746.060759.500 758.156EUR 54,587 815.76
2025-05-12SELL-72755.570765.330 764.354EUR -55,033 820.72 Profit of 4,058 on sale
2025-05-09BUY72734.570762.010 759.266EUR 54,667 821.90
2025-05-08BUY72751.450769.980 768.127EUR 55,305 822.88
2025-05-07BUY72776.720784.340 783.578EUR 56,418 823.53
2025-05-06BUY72775.120818.420 814.090EUR 58,614 824.22
2025-05-05BUY72821.460829.640 828.822EUR 59,675 824.26
2025-05-02BUY72823.620831.530 830.739EUR 59,813 824.27
2025-05-01BUY72794.100850.930 845.247EUR 60,858 824.72
2025-04-30BUY72898.950902.500 902.145EUR 64,954 823.59
2025-04-29BUY72885.200892.470 891.743EUR 64,205 822.65
2025-04-28BUY72877.290882.250 881.754EUR 63,486 821.79
2025-04-25BUY72884.540885.580 885.476EUR 63,754 820.80
2025-04-24BUY72859.730862.250 861.998EUR 62,064 820.17
2025-04-23BUY72829.420846.010 844.351EUR 60,793 820.02
2025-04-22BUY72827.540832.000 831.554EUR 59,872 819.89
2025-04-21BUY72818.020843.910 841.321EUR 60,575 819.92
2025-04-18BUY72 839.972* 819.58
2025-04-17BUY72839.960858.000 856.196EUR 61,646 819.22
2025-04-16BUY72734.900756.300 754.160EUR 54,300 820.73
2025-04-15BUY72757.180765.310 764.497EUR 55,044 821.88
2025-04-14BUY72754.350759.560 759.039EUR 54,651 823.13
2025-04-11BUY72732.410735.840 735.497EUR 52,956 824.84
2025-04-10BUY72720.910741.950 739.846EUR 53,269 826.84
2025-04-09BUY72753.710754.830 754.718EUR 54,340 828.28
2025-04-08BUY72726.240763.500 759.774EUR 54,704 830.32
2025-04-07BUY72723.730748.000 745.573EUR 53,681 832.49
2025-04-04BUY72738.210768.270 765.264EUR 55,099 834.46
2025-04-02BUY72818.220819.850 819.687EUR 59,017 834.80
2025-04-01BUY72805.230820.660 819.117EUR 58,976 835.45
2025-03-31BUY72825.910828.010 827.800EUR 59,602 835.66
2025-03-28BUY72822.510829.780 829.053EUR 59,692 835.96
2025-03-27BUY72821.670826.770 826.260EUR 59,491 836.29
2025-03-26BUY72826.760851.410 848.945EUR 61,124 836.52
2025-03-25BUY72852.350874.920 872.663EUR 62,832 836.13
2025-03-24BUY72864.900866.870 866.673EUR 62,400 835.41
2025-03-21BUY72837.570850.430 849.144EUR 61,138 835.35
2025-03-20BUY72842.570854.390 853.208EUR 61,431 835.16
2025-03-19BUY72837.010842.130 841.618EUR 60,596 835.11
2025-03-18BUY72822.510836.290 834.912EUR 60,114 835.46
2025-03-17BUY72824.760829.000 828.576EUR 59,657 835.77
2025-03-14BUY72813.480815.210 815.037EUR 58,683 836.43
2025-03-13BUY72801.650821.110 819.164EUR 58,980 837.48
2025-03-12BUY72821.860834.650 833.371EUR 60,003 837.97
2025-03-11BUY72824.060832.350 831.521EUR 59,870 838.42
2025-03-10BUY72829.760863.190 859.847EUR 61,909 838.71
2025-03-07BUY72869.580908.000 904.158EUR 65,099 837.64
2025-03-05BUY72929.720930.490 930.413EUR 66,990 834.35
2025-03-04BUY72911.060929.160 927.350EUR 66,769 831.51
2025-03-03BUY72929.720935.630 935.039EUR 67,323 827.74
2025-02-28BUY72920.630921.220 921.161EUR 66,324 824.02
2025-02-27BUY72905.160925.500 923.466EUR 66,490 820.64
2025-02-26BUY72915.010922.430 921.688EUR 66,362 816.54
2025-02-25BUY72901.800912.000 910.980EUR 65,591 812.66
2025-02-24BUY72881.400893.110 891.939EUR 64,220 809.39
2025-02-21BUY72873.680894.400 892.328EUR 64,248 806.17
2025-02-20BUY72873.120880.320 879.600EUR 63,331 802.65
2025-02-19BUY72867.050881.330 879.902EUR 63,353 799.07
2025-02-18SELL-72857.200862.730 862.177EUR -62,077 828.72 Loss of -2,409 on sale
2024-11-12SELL-388818.860833.990 832.477EUR -323,001 863.02 Profit of 11,850 on sale
2024-11-04SELL-388806.140820.190 818.785EUR -317,689 889.30 Profit of 27,361 on sale
2024-10-30SELL-388846.830860.500 859.133EUR -333,344 902.41 Profit of 16,791 on sale
2024-10-29SELL-388903.580907.980 907.540EUR -352,126 903.38 Loss of -1,613 on sale
2024-10-28SELL-388895.590898.210 897.948EUR -348,404 905.16 Profit of 2,800 on sale
2024-10-24BUY388891.320900.000 899.132EUR 348,863 912.08
2024-10-23BUY388903.250907.950 907.480EUR 352,102 915.03
2024-10-21SELL-388906.130918.860 917.587EUR -356,024 917.97 Profit of 148 on sale
2024-10-18BUY388917.970920.920 920.625EUR 357,202 0.00
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of LLY

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19432,0389351,319,85332.7%
2025-09-18547,8181261,290,14742.5%
2025-09-17437,3374271,166,20437.5%
2025-09-16532,6981,8291,463,37436.4%
2025-09-15424,9797011,071,48739.7%
2025-09-12267,121172826,80232.3%
2025-09-11249,8031,484850,46129.4%
2025-09-10415,4421,025989,00842.0%
2025-09-09559,8056671,270,80044.1%
2025-09-08856,0184,6821,937,44744.2%
2025-09-05679,2761,0501,405,23948.3%
2025-09-04337,49153982,75134.3%
2025-09-03214,691496766,15728.0%
2025-09-02430,4772,9771,131,90838.0%
2025-08-29357,538602889,50940.2%
2025-08-28433,6871,0991,113,56838.9%
2025-08-27860,7156,0091,681,35351.2%
2025-08-261,548,46012,1052,955,34852.4%
2025-08-25566,4543,5861,323,24942.8%
2025-08-22749,6151,9571,460,71351.3%
2025-08-21651,6392231,570,06741.5%
2025-08-20679,5542,6981,870,24136.3%
2025-08-19787,9099352,788,74028.3%
2025-08-18756,1431,0951,727,60343.8%
2025-08-151,814,7218363,422,26053.0%
2025-08-141,852,9405,3823,602,82951.4%
2025-08-131,254,2253,4732,774,10045.2%
2025-08-12990,1103,1902,845,89634.8%
2025-08-111,290,0631,6155,196,30224.8%
2025-08-082,448,706300,8706,239,83039.2%
2025-08-074,197,951489,61810,364,29440.5%
2025-08-06440,1441,1201,811,26224.3%
2025-08-05331,460921993,17833.4%
2025-08-04474,9051,4081,273,99537.3%
2025-08-01530,5697,1391,882,09828.2%
2025-07-31882,5063,6702,110,03041.8%
2025-07-30745,6143921,827,43540.8%
2025-07-291,081,8495712,607,24541.5%
2025-07-28304,8417,4601,004,03230.4%
2025-07-25365,4172651,055,27334.6%
2025-07-24321,7997621,167,14727.6%
2025-07-23485,7193,4711,044,91946.5%
2025-07-22241,0983,036874,71727.6%
2025-07-21418,0148541,180,44535.4%
2025-07-18623,4986511,225,33350.9%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.